Early cyst growth is associated with the increased nuclear expression of cyclin D1/Rb protein in an autosomal-recessive polycystic kidney disease rat model

Nephron - Experimental Nephrology

Volumn 117, Issue 4, 2011, Pages

  Schwensen, Kristina G ^a   Burgess, Jane S ^a   Graf, Nicole S ^b   Alexander, Stephen I ^b   Harris, David C ^a   Phillips, Jacqueline K ^c,d   Rangan, Gopala K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

^d MURDOCH UNIVERSITY   (Australia)

Author keywords

Cyclin; Polycystic kidney disease; Proliferation

Indexed keywords

CYCLIN D1; CYCLIN E; KI 67 ANTIGEN; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; MALE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; CELL NUCLEUS; CELL PROLIFERATION; CYCLIN D1; CYSTS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; POLYCYSTIC KIDNEY, AUTOSOMAL RECESSIVE; RATS; RATS, INBRED LEW; RETINOBLASTOMA PROTEIN; TIME FACTORS;

EID: 77957298655     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320149     Document Type: Article

References (32)

1. Wilson PD: Polycystic kidney disease. N Engl J Med 2004; 350: 151-164.
2. Grantham JJ: Clinical practice: autosomal dominant polycystic kidney disease. N Engl J Med 2008; 359: 1477-1485.
3. Sweeney WE Jr, Avner ED: Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tissue Res 2006; 326: 671-685.
4. Nadasdy T, Laszik Z, Lajoie G, Blick KE, Wheeler DE, Silva FG: Proliferative activity of cyst epithelium in human renal cystic diseases. J Am Soc Nephrol 1995; 5: 1462-1468.
5. Evan AP, Gardner KD Jr, Bernstein J: Polypoid and papillary epithelial hyperplasia: a potential cause of ductal obstruction in adult polycystic disease. Kidney Int 1979; 16: 743-750. (Pubitemid 10063528)
6. Grantham JJ, Geiser JL, Evan AP: Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int 1987; 31: 1145-1152. (Pubitemid 17069098)
7. Wang X, Gattone V, 2nd, Harris PC, Torres VE: Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol 2005; 16: 846-851. (Pubitemid 41710293)
8. Nagao S, Nishii K, Yoshihara D, Kurahashi H, Nagaoka K, Yamashita T, Takahashi H, Yamaguchi T, Calvet JP, Wallace DP: Calcium channel inhibition accelerates polycystic kidney disease progression in the cy/+ rat. Kidney International 2008; 73: 269-277.
9. Kumar V, Abbas AK, Fausto N: Tissue renewal and repair: regeneration, healing and fibrosis; in Kumar V, Abbas AK, Fausto N (eds): Robbins and Cotran Pathologic Basis of Disease. Philadelphia, Elsevier Saunders, 2005, vol 1.
10. Obaya AJ, Sedivy JM: Regulation of cyclin-CDK activity in mammalian cells. Cell Mol Life Sci 2002; 59: 126-142. (Pubitemid 34117361)
11. Vermeulen K, Van Bockstaele DR, Berneman ZN: The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Proliferation 2003; 36: 131-149. (Pubitemid 36808270)
12. Malumbres M, Barbacid M: Cell cycle, CDKS and cancer: a changing paradigm. Nat Rev Cancer 2009; 9: 153-166.
13. Kim JK, Diehl JA: Nuclear cyclin d1: an oncogenic driver in human cancer. J Cell Physiol 2009; 220: 292-296.
14. Hwang HC, Clurman BE: Cyclin E in normal and neoplastic cell cycles. Oncogene 2005; 24: 2776-2786. (Pubitemid 40638089)
15. Genovese C, Trani D, Caputi M, Claudio PP: Cell cycle control and beyond: Emerging roles for the retinoblastoma gene family. Oncogene 2006; 25: 5201-5209. (Pubitemid 44299078)
16. Bukanov NO, Smith LA, Klinger KW, Ledbetter SR, Ibraghimov-Beskrovnaya O: Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 2006; 444: 949-952. (Pubitemid 46025010)
17. Park JY, Schutzer WE, Lindsley JN, Bagby SP, Oyama TT, Anderson S, Weiss RH: P21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels. BMC Nephrol 2007; 8: 12.
18. Alcalay NI, Sharma M, Vassmer D, Chapman B, Paul B, Zhou J, Brantley JG, Wallace DP, Maser RL, van den Heuvel GB: Acceleration of polycystic kidney disease progression in CPK mice carrying a deletion in the home-odomain protein cux1. Am J Physiol Renal Physiol 2008; 295:F1725-F1734.
19. Sugiyama K, Akiyama T, Shimizu M, Tamaoki T, Courage C, Gescher A, Akinaga S: Decrease in susceptibility toward induction of apoptosis and alteration in g1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-hydroxystaurosporine). Cancer Res 1999; 59: 4406-4412. (Pubitemid 29418761)
20. Phillips JK, Hopwood D, Loxley RA, Ghatora K, Coombes JD, Tan YS, Harrison JL, Mc- Kitrick DJ, Holobotvskyy V, Arnolda LF, Rangan GK: Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease. Kidney Blood Pressure Res 2007; 30: 129-144. (Pubitemid 46976031)
21. Rangan GK, Tesch GH: Quantification of renal pathology by image analysis. Nephrology 2007; 12: 553-558.
22. Krajewska M, Smith LH, Rong J, Huang X, Hyer ML, Zeps N, Iacopetta B, Linke SP, Olson AH, Reed JC, Krajewski S: Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sections. J Histochem Cytochem 2009; 57: 649-663.
23. Vogetseder A, Picard N, Gaspert A, Walch M, Kaissling B, Le Hir M: Proliferation capacity of the renal proximal tubule involves the bulk of differentiated epithelial cells. Am J Physiol Cell Physiol 2008; 294:C22-C28.
24. Cowley BD Jr, Chadwick LJ, Grantham JJ, Calvet JP: Elevated proto-oncogene expression in polycystic kidneys of the c57bl/6j (cpk) mouse. J Am Soc Nephrol 1991; 1: 1048-1053.
25. Cowley BD Jr, Smardo FL Jr, Grantham JJ, Calvet JP: Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease. Proc Natl Acad Sci USA 1987; 84: 8394-8398.
26. Aaltonen K, Amini RM, Landberg G, Eerola H, Aittomaki K, Heikkila P, Nevanlinna H, Blomqvist C: Cyclin d1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer. Breast Cancer Res Treat 2009; 113: 75-82.
27. Loden M, Stighall M, Nielsen NH, Roos G, Emdin SO, Ostlund H, Landberg G: The cyclin d1 high and cyclin e high subgroups of breast cancer: Separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the prb node. Oncogene 2002; 21: 4680-4690. (Pubitemid 34833145)
28. Lindahl T, Landberg G, Ahlgren J, Nordgren H, Norberg T, Klaar S, Holmberg L, Bergh J: Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer. Carcinogenesis 2004; 25: 375-380. (Pubitemid 38344404)
29. Bhunia AK, Piontek K, Boletta A, Liu L, Qian F, Xu PN, Germino FJ, Germino GG: Pkd1 induces p21(waf1) and regulation of the cell cycle via direct activation of the jak-stat signaling pathway in a process requiring pkd2. Cell 2002; 109: 157-168. (Pubitemid 34518255)
30. Li X, Luo Y, Starremans PG, McNamara CA, Pei Y, Zhou J: Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor ID2. Nat Cell Biol 2005; 7: 1202-1212.
31. McCausland JE, Ryan GB, Alcorn D: Angio-tensin converting enzyme inhibition in the postnatal rat results in decreased cell proliferation in the renal outer medulla. Clin Exp Pharmacol Physiol 1996; 23: 552-554. (Pubitemid 26186438)
32. Henry A, Reyes-Mugica M: Autosomal recessive polycystic kidney disease associated with nephrogenic rests: a possible consequence of arrested renal maturation. Pediatr Dev Pathol 2009: 12:493-494.